Baird Medical has received new Class III certificate for its ceramic thyroid ablation needle from China’s National Medical Products Administration (NMPA).

The certificate recognises the needle’s advanced design for treating thyroid nodules, utilising rare earth ceramic materials for improved heat resistance, chemical stability, and electrical insulation.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Baird Medical’s needle is designed to distribute energy uniformly within the tissue during microwave ablation treatments. This reduces edge heating effects and increases mechanical strength by an estimated 30%.

The improvement in material strength enhances the needle’s flexibility and reliability, crucial for the precision required in delicate surgeries. The needle’s robust construction also minimises the risk of breakage.

Baird Medical founder and CEO Haimei Wu said: “The introduction of the Ceramic Thyroid Ablation Needle signifies another breakthrough innovation in the field of microwave ablation and is a testament to our ongoing commitment to innovation and research.

“We eagerly anticipate the positive impact of this technology by enhancing the patient treatment experiences and saving lives in the years to come.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The ceramic materials used in the needle optimise heating, allowing for more consistent microwave energy penetration and a 20-30% increase in heating efficiency. High-temperature sintering technology and specialised processes for connecting the needle shaft contribute to this heightened efficiency.

The NMPA’s 2023 updates to the Medical Device Classification Catalog saw Microwave Ablation Devices reclassified from Class II to Class III.

In November 2023, the US Food and Drug Administration (FDA) cleared Baird Medical’s microwave ablation (MWA) system and disposable needles for use in the US.

The technology helps to ablate thyroid nodules, breast tumours and other diseases where soft tissue needs to be removed.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact